Editor’s Note: Amanda Pratt’s first contribution to our Pharmaceutical Inequalities series offers this insightful interview with Vincent Wartenweiler PharmD, an independent community pharmacist and Master’s student in Psychoactive Pharmaceutical Investigation at UW-Madison. Amanda (AP) and Vincent (VW) sat down on March 24, 2022 to discuss a qualitative project Vincent published in 2021 to determine perceptions of pharmacy stakeholders around opioid use disorder vaccines. In addition to providing a glimpse into a significant milestone for the history of alcohol, drugs and pharmacy–the development of substance use disorder vaccines–this interview sheds light on potential methodologies for understanding vaccine hesitancy. The Pharmaceutical Inequalities series is funded by the Holtz Center and the Evjue Foundation.
The State of Drug Checking in the United Kingdom
In a context where drug overdose deaths and other drug-related harms are on the rise, epidemiological evidence-backed harm reduction services including drug checking, drug consumption rooms, and needle exchanges are a crucial priority. In this post, Contributing Editor Juliet Flam-Ross describes the state of drug checking services in the UK.